dynaCERT Logo.jpg
dynaCERT Establishes Strategic Alliance with MOSOLF Group of Europe
16 oct. 2019 08h58 HE | dynaCERT Inc.
TORONTO, Oct. 16, 2019 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) (“dynaCERT” or the “Company”) is pleased to announce that it has concluded three (3) agreements...
dynaCERT Logo.jpg
dynaCERT Obtains European Approval of its Hydrogen Technology
26 août 2019 09h15 HE | dynaCERT Inc.
TORONTO, Aug. 26, 2019 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) is very pleased to announce that its wholly-owned European subsidiary, dynaCERT GmbH,...
dynaCERT Logo.jpg
dynaCERT Strengthens Its Intellectual Property Advancing Global Sustainability
22 août 2019 05h00 HE | dynaCERT Inc.
TORONTO, Aug. 22, 2019 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to provide significant updates related to the...
dynaCERT Logo.jpg
dynaCERT Receives the Notice of Allowance for a Patent for its SMART ECU
02 mai 2019 14h32 HE | dynaCERT Inc.
TORONTO, May 02, 2019 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to announce that it has received a Notice of Allowance...
dynaCERT Logo.jpg
dynaCERT Secures its First Ontario Trucking Fleet Order
11 avr. 2019 07h00 HE | dynaCERT Inc.
TORONTO, April 11, 2019 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to announce that it has received a purchase order for...
dynaCERT Logo.jpg
dynaCERT Patent Granted
09 avr. 2019 18h04 HE | dynaCERT Inc.
TORONTO, April 09, 2019 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to announce that a U.S. patent (U.S. Patent No....
NANOBIOTIX ANNONCE L
NANOBIOTIX ANNONCE LA TOUTE PREMIERE AUTORISATION DE MISE SUR LE MARCHÉ EUROPEEN D’UN RADIOENHANCER
04 avr. 2019 12h31 HE | NANOBIOTIX
NANOBIOTIX ANNONCE LA TOUTE PREMIERE AUTORISATION DE MISE SUR LE MARCHÉ EUROPEEN D’UN RADIOENHANCER Hensify®(NBTXR3) a reçu une autorisation de mise sur le marché (Marquage CE) en Europe...
Nanobiotix Announces
Nanobiotix Announces First Ever Radioenhancer to Receive European Market Approval
04 avr. 2019 12h31 HE | NANOBIOTIX
NANOBIOTIX ANNOUNCES FIRST EVER RADIOENHANCER TO RECEIVE EUROPEAN MARKET APPROVAL Hensify®(NBTXR3) received European market approval (CE mark) enabling commercialization in 27 European Union...
dynaCERT_web_WBack Jan 2017.png
dynaCERT Announces Appointment of Brian Semkiw to its Advisory Board
01 mars 2019 07h00 HE | dynaCERT Inc.
TORONTO, March 01, 2019 (GLOBE NEWSWIRE) -- dynaCERT Inc. (TSX VENTURE: DYA) (OTCQB: DYFSF) (FRA: DMJ) ("dynaCERT" or the "Company") is pleased to announce that it has appointed Mr. Brian Semkiw...
Equillium Logo.png
Equillium Granted U.S. FDA Orphan Drug Designations for EQ001 (itolizumab) for both the Prevention and Treatment of Acute Graft-Versus-Host Disease
07 févr. 2019 08h08 HE | Equillium
LA JOLLA, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company developing treatments for severe immuno-inflammatory disorders, today announced that the...